一种无需提取即可实现超灵敏检测外泌体PD-L1的单步免疫磁珠-RPA-CRISPR/Cas13a平台
An extraction-free one-pot immunomagnetic-RPA-CRISPR/Cas13a platform for ultrasensitive detection of exosomal PD-L1
Hansen Shi, Jiayi Chen, Xiaocong Lin, Yaning Zhang, Haiqi Wu, Biyun Zeng, Peijun Zhang, Qianying Luo, Tiancai Liu, Tao Zeng
Journal:ANALYTICA CHIMICA ACTA
IF:6.1
DOI:10.1016/j.aca.2026.346335
PMID:
Published:2026-09-29
research field:细胞外囊泡生物传感器开发肿瘤免疫治疗核酸扩增分子诊断
Abstract
An extraction-free one-pot iMRO-HCRISPR platform integrates immunomagnetic bead capture, RPA amplification, and CRISPR/Cas13a signal amplification in a single closed tube. • It achieves a detection limit of 10 1 particles/mL with a quantitative range spanning eight orders of magnitude (10 3 –10 11 particles/mL). • It distinguishes HCC patients from healthy controls with an area under the receiver operating characteristic curve (AUC) of 0.964 (P < 0.0001). • Toehold-mediated strand displacement purification effectively eliminates non-specific binding and markedly reduces background signals. • The antibody-swappable design allows adaptation to other tumor exosome biomarkers, supporting routine clinical testing and rapid point-of-care testing (POCT). Programmed death-ligand 1 (PD-L1) expressed on the surface of exosomes (exo) is a promising liquid biopsy biomarker for monitoring response to immunotherapy in hepatocellular carcinoma (HCC). However, existing detection methods are limited by insufficient sensitivity and complicated operation. To address this, we developed an extraction-free immunomagnetic recombinase polymerase amplification (RPA)-based one-pot high-sensitivity CRISPR/Cas13a platform (iMRO-HCRISPR) employing DNA-conjugated antibodies. Exosomes in blood were enriched with anti-CD63/CD81/CD9 antibody-conjugated magnetic beads and recognized by PD-L1-specific DNA-antibody probes; the probe DNA then underwent RPA amplification, in vitro transcription (IVT), and Cas13a trans-cleavage, achieving multi-level signal amplification with fluorescent readout. Toehold-mediated DNA affinity pull-down effectively reduced the detection background. The platform achieved a limit of detection (LOD) as low as 10 1 particles/mL (positive detection at the single-particle level), a limit of quantification (LOQ) of 10 3 particles/mL, and a quantitative range of 10 3 –10 11 particles/mL, with the entire process completed in a single closed tube without exosome isolation. C
本文使用的Yeasen产品
南美超级胎牛血清999尝鲜特惠


